Home / Inspections / 1324654

FDA Inspection 1324654 — Joshua E. Reuss, MD

Joshua E. Reuss, MD — FEI 3044738236

The FDA completed an inspection of Joshua E. Reuss, MD on Jun 10, 2026 in Washington, DC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jun 10, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Washington, DC (United States)

Additional Details

Clinical Investigator (CI)

Facility

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.